These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33860719)

  • 1. Role of macrophage in nanomedicine-based disease treatment.
    Song S; Xia H; Guo M; Wang S; Zhang S; Ma P; Jin Y
    Drug Deliv; 2021 Dec; 28(1):752-766. PubMed ID: 33860719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine at the crossroads - A quick guide for IVIVC.
    Mast MP; Modh H; Champanhac C; Wang JW; Storm G; Krämer J; Mailänder V; Pastorin G; Wacker MG
    Adv Drug Deliv Rev; 2021 Dec; 179():113829. PubMed ID: 34174332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities.
    Xu Z; Xu Y; Zhang K; Liu Y; Liang Q; Thakur A; Liu W; Yan Y
    J Nanobiotechnology; 2023 Mar; 21(1):114. PubMed ID: 36978093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.
    He W; Kapate N; Shields CW; Mitragotri S
    Adv Drug Deliv Rev; 2020; 165-166():15-40. PubMed ID: 31816357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines for dysfunctional macrophage-associated diseases.
    He H; Ghosh S; Yang H
    J Control Release; 2017 Feb; 247():106-126. PubMed ID: 28057522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
    Patel SK; Janjic JM
    Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanomedicine platforms for cancer therapy.
    Zhang H
    J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of ulcerative colitis
    Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
    Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management.
    Liu H; Lv H; Duan X; Du Y; Tang Y; Xu W
    Int J Nanomedicine; 2023; 18():6915-6940. PubMed ID: 38026516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.
    Jahromi LP; Shahbazi MA; Maleki A; Azadi A; Santos HA
    Adv Sci (Weinh); 2021 Apr; 8(8):2002499. PubMed ID: 33898169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine delivers promising treatments for rheumatoid arthritis.
    Prasad LK; O'Mary H; Cui Z
    Nanomedicine (Lond); 2015; 10(13):2063-74. PubMed ID: 26084368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.
    Ranganathan R; Madanmohan S; Kesavan A; Baskar G; Krishnamoorthy YR; Santosham R; Ponraju D; Rayala SK; Venkatraman G
    Int J Nanomedicine; 2012; 7():1043-60. PubMed ID: 22403487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nanomedicine mechanical properties on tumor targeting delivery.
    Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
    Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.